近日，西(xi)藏衛(wei)信康(kang)醫(yi)藥(yao)股份(fen)有(you)(you)限公(gong)(gong)司(si)（以(yi)下(xia)簡稱(cheng)“公(gong)(gong)司(si)”）全資子公(gong)(gong)司(si)內(nei)蒙(meng)古白醫(yi)制(zhi)藥(yao)股份(fen)有(you)(you)限公(gong)(gong)司(si)（以(yi)下(xia)簡稱(cheng)“白醫(yi)制(zhi)藥(yao)”）收到(dao)國家(jia)藥(yao)品(pin)監督管理局（以(yi)下(xia)簡稱(cheng)“國家(jia)藥(yao)監局”）核準(zhun)簽發的門(men)冬氨(an)酸鉀鎂注射液(ye)《藥(yao)品(pin)補充申請(qing)批(pi)準(zhun)通知書(shu)》，該(gai)藥(yao)品(pin)通過(guo)仿制(zhi)藥(yao)質量(liang)和療效(xiao)一致(zhi)性(xing)評價。